Filing Details
- Accession Number:
- 0001415889-25-007506
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-03-10 16:11:28
- Reporting Period:
- 2024-04-17
- Filing Date:
- 2025-03-10
- Accepted Time:
- 2025-03-10 16:11:28
- Original Submission Date:
- 2024-09-27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1709941 | Bioage Labs Inc. | BIOA | Pharmaceutical Preparations (2834) | 474721157 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1771213 | Rekha Hemrajani | C/O Bioage Labs, Inc. 1445A South 50Th Street Richmond CA 94804 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-27 | 3,000 | $18.00 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
